Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Entest Group Inc ETNI

Entest Group, Inc., formerly Entest Biomedical, Inc., is engaged in the business combination with an unidentified company. The Company has not entered into any definitive agreement with any party, nor have there been any specific discussions with any potential business combination candidate regarding business opportunities for the Company.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:ETNI)

Entest Group, Inc. Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.

PR Newswire May 10, 2018

Entest BioMedical Inc. Announces 3 Million Share Zander Therapeutics, Inc. Dividend to be Paid to Shareholders

PR Newswire September 29, 2017

Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board

PR Newswire September 13, 2017

Zander Therapeutics, Inc. Reports Research Demonstrating Ex-Vivo Immune Suppression of IL-17a and IL-2 in Dogs With Novel NR2F6 Activators

PR Newswire July 26, 2017

Zander Therapeutics Inc. Announces Brian Devine, Former Chairman of PETCO, to Helm its Business Advisory Board

PR Newswire June 27, 2017

Entest BioMedical's Subsidiary Zander Therapeutics, Inc., Reports Its Series A Compounds Suppressed the Production of Multiple Cytokines Known to be Involved in Inflammation With No Toxicity In Canine Studies

PR Newswire June 13, 2017

Entest BioMedical's Subsidiary Zander Therapeutics, Inc. Reports on Preliminary Canine Experiments Testing New Anti-Inflammatory Drug Compounds

PR Newswire June 7, 2017

Entest BioMedical, Inc. Settles $841,531 of Principal Indebtedness Through the Issuance of Equity Securities

PR Newswire May 31, 2017

Entest BioMedical Inc. Subsidiary Zander Therapeutics Discusses Developments in Medicinal Chemistry for Veterinary Applications of Cancer and Autoimmune Therapies Through Modulation of Checkpoint NR2F6

PR Newswire May 23, 2017

Opinion & Analysis (GREY:ETNI)

No current opinion is available.

Bullboard Posts (GREY:ETNI)

RE:One Year since Brandon Dean started custodianship for ETNI

I am desperate for any information re ETNI.  Apparently traders in Canada are the only ones able to buy ETNI, even then I think it...
rockingrooster - January 14, 2024

One Year since Brandon Dean started custodianship for ETNI

Wonder what the next step is.Anyone with any knowledge?
rockingrooster - November 1, 2023

RE:NEXT STEP........

DISMISSED
rockingrooster - June 27, 2023

NEXT STEP........

06/27/2023 Show Cause Hearing  Judicial Officer Delaney, Kathleen E. Hearing Time 9:00 AM
rockingrooster - May 30, 2023

Since no else is posting on this board,I going to stop....

informing myself.There has to be someone out there that can contribute.Anything on Brandon Dean? Any next steps ? etc. etc.
rockingrooster - March 13, 2023

Custodian status check now Feb28/23

02/28/2023 Status Check  Judicial Officer Delaney, Kathleen E. Hearing Time 9:00 AM Comment Status ChecK...
rockingrooster - January 30, 2023